Comment
. 2012 May;16(5):701; author reply 702.
doi: 10.5588/ijtld.12.0131.
Location of Xpert® MTB/RIF in centralised laboratories in South Africa undermines potential impact
- PMID: 22507934
- DOI: 10.5588/ijtld.12.0131
Item in Clipboard
Comment
Location of Xpert® MTB/RIF in centralised laboratories in South Africa undermines potential impact
Int J Tuberc Lung Dis.
2012 May.
No abstract available
Comment on
-
Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?Int J Tuberc Lung Dis. 2011 Dec;15(12):1567-72. doi: 10.5588/ijtld.11.0392. Epub 2011 Oct 13. Int J Tuberc Lung Dis. 2011. PMID: 22005110
Similar articles
-
Should Xpert® MTB/RIF be rolled out in low-income countries?Int J Tuberc Lung Dis. 2012 May;16(5):702-3; author reply 703-4. doi: 10.5588/ijtld.12.0034. Int J Tuberc Lung Dis. 2012. PMID: 22507936 No abstract available.
-
The ethics of national tuberculosis programmes in low-income countries not rolling out Xpert ® MTB/RIF.Int J Tuberc Lung Dis. 2011 Dec;15(12):1563. doi: 10.5588/ijtld.11.0728. Int J Tuberc Lung Dis. 2011. PMID: 22118160 No abstract available.
-
The Xpert® MTB/RIF assay evaluation in South Korea, a country with an intermediate tuberculosis burden.Int J Tuberc Lung Dis. 2012 Nov;16(11):1471-6. doi: 10.5588/ijtld.11.0602. Epub 2012 Sep 12. Int J Tuberc Lung Dis. 2012. PMID: 22981162
-
Impact of the Xpert MTB/RIF diagnostic test for tuberculosis in countries with a high burden of disease.Curr Opin Pulm Med. 2015 May;21(3):304-8. doi: 10.1097/MCP.0000000000000161. Curr Opin Pulm Med. 2015. PMID: 25764020 Review.
-
Xpert® MTB/RIF: Usefulness for the diagnosis of tuberculosis and resistance to rifampicin.Med Clin (Barc). 2017 Nov 9;149(9):399-405. doi: 10.1016/j.medcli.2017.06.007. Epub 2017 Jul 22. Med Clin (Barc). 2017. PMID: 28739268 Review. English, Spanish.
Cited by
-
Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies.BMC Infect Dis. 2013 Sep 3;13:407. doi: 10.1186/1471-2334-13-407. BMC Infect Dis. 2013. PMID: 24004840 Free PMC article.
-
Implementation Research to Inform the Use of Xpert MTB/RIF in Primary Health Care Facilities in High TB and HIV Settings in Resource Constrained Settings.PLoS One. 2015 Jun 1;10(6):e0126376. doi: 10.1371/journal.pone.0126376. eCollection 2015. PLoS One. 2015. PMID: 26030301 Free PMC article.
-
An Optimal Diagnostic Strategy for Tuberculosis in Hospitalized HIV-Infected Patients Using GeneXpert MTB/RIF and Alere Determine TB LAM Ag.J Clin Microbiol. 2020 Sep 22;58(10):e01032-20. doi: 10.1128/JCM.01032-20. Print 2020 Sep 22. J Clin Microbiol. 2020. PMID: 32727831 Free PMC article. Clinical Trial.
-
Quality of TB diagnostic services at primary healthcare clinics in eThekwini district, South Africa.PLoS One. 2024 Jul 18;19(7):e0307149. doi: 10.1371/journal.pone.0307149. eCollection 2024. PLoS One. 2024. PMID: 39024321 Free PMC article.
-
Impact of an optimized care model for advanced HIV disease: a non-randomized cluster study in Malawi.BMC Public Health. 2025 Aug 16;25(1):2802. doi: 10.1186/s12889-025-24157-2. BMC Public Health. 2025. PMID: 40819079 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
